318 related articles for article (PubMed ID: 6696458)
1. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
2. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B.
Kagawa T; Morizane T; Saito H; Tsunematsu S; Tada S; Kumagai N; Tsuchimoto K; Sugiura H; Mukai M; Tsuchiya M
Am J Gastroenterol; 1993 Feb; 88(2):212-6. PubMed ID: 8424423
[TBL] [Abstract][Full Text] [Related]
4. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
[TBL] [Abstract][Full Text] [Related]
7. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
8. Changes of intrahepatic localization of hepatitis B core antigen in HBeAg positive patients with chronic active hepatitis B treated with interferon.
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Iwai M; Kashima K; Sokawa Y
Am J Gastroenterol; 1990 Jun; 85(6):660-4. PubMed ID: 2191593
[TBL] [Abstract][Full Text] [Related]
9. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of a low dosage of human leukocyte interferon on chronic hepatitis B virus infection.
Matsumura N; Yoshikawa T; Kondo M; Kawakami H; Kishida T
Digestion; 1983; 26(4):205-12. PubMed ID: 6873506
[TBL] [Abstract][Full Text] [Related]
11. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
12. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
14. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
[TBL] [Abstract][Full Text] [Related]
15. Interferon in chronic active hepatitis B. Preliminary results.
Waked I; Amin M; Abd-el Fattah SA; Osman L; Sabbour M
Chemioterapia; 1988 Jun; 7(3):198-202. PubMed ID: 3168077
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz J; Cummins J; Georgiades J
Przegl Epidemiol; 1991; 45(4):325-30. PubMed ID: 1841411
[TBL] [Abstract][Full Text] [Related]
18. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Perrillo R; Campbell C; Wellinghoff W; Gelb L
Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
[TBL] [Abstract][Full Text] [Related]
19. Recombinant leukocyte interferon treatment of chronic hepatitis B.
Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of viral hepatitis. b) Anti-virus agents].
Matsushima T
Hokkaido Igaku Zasshi; 1984 May; 59(3):238-44. PubMed ID: 6479842
[No Abstract] [Full Text] [Related]
[Next] [New Search]